Kinetics of inhibitors of ADAMTS13 in three patients with severe thrombotic thrombocytopenic purpura (TTP).

被引:0
|
作者
Knoebl, P
Varadi, K
Schreiner, J
Kyrle, P
Pabinger, I
Turecek, PL
机构
[1] Univ Vienna, Dept Med 1, A-1010 Vienna, Austria
[2] Baxter Biosci, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2706
引用
收藏
页码:686A / 687A
页数:2
相关论文
共 50 条
  • [21] Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience
    Jang, Moon Ju
    Chong, So Young
    Kim, In-Ho
    Kim, Jee-Hyun
    Jung, Chul-Won
    Kim, Ja Young
    Park, Ji-Chan
    Lee, Sun Min
    Kim, Yeo-Kyeoung
    Lee, Ji-Eun
    Jang, Sung-Su
    Kim, Jin-Seok
    Jo, Deog-Yeon
    Zang, Dae-Young
    Lee, Young-Yiul
    Yhim, Ho-Young
    Oh, Doyeun
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (02) : 163 - 169
  • [22] Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience
    Moon Ju Jang
    So Young Chong
    In-Ho Kim
    Jee-Hyun Kim
    Chul-Won Jung
    Ja Young Kim
    Ji-Chan Park
    Sun Min Lee
    Yeo-Kyeoung Kim
    Ji-Eun Lee
    Sung-Su Jang
    Jin-Seok Kim
    Deog-Yeon Jo
    Dae-Young Zang
    Young-Yiul Lee
    Ho-Young Yhim
    Doyeun Oh
    International Journal of Hematology, 2011, 93 : 163 - 169
  • [23] Impact of severe ADAMTS-13 deficiency in patients with thrombotic thrombocytopenic purpura (TTP) on recurrences
    Russo, L.
    Marchetti, M.
    Testa, M.
    Brevi, S.
    Barcella, L.
    Carpenedo, M.
    Noris, M.
    Savignano, C.
    Billio, A.
    Franco, Bruno M.
    Toschi, V
    Falanga, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 126 - 127
  • [24] Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura - Reply
    Kelton, JG
    TRANSFUSION, 2002, 42 (11) : 1524 - 1525
  • [25] Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura
    Bendapudi, Pavan K.
    Foy, Brody H.
    Mueller, Sarah B.
    Liu, Jun
    Feingold, Louis M.
    Burke, Kristen E.
    Cruz, Wendy
    Chen, Maria Y.
    Lau, Emily S.
    Goldberg, Rachel L.
    Tatake, Ishan
    Wilkinson, Shelby C.
    Carney, Brian J.
    Stone, James R.
    Park, Doyun
    Avelino, Alzira R.
    Hassan, Sajjad
    Andrzejewski, Chester
    Ruby, Kristen N.
    Friedman, Kenneth D.
    Brunker, Patricia A. R.
    Leaf, Rebecca K.
    Higgins, John
    Dzik, Walter H.
    Stefely, Jonathan A.
    Makar, Robert S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (18): : 1690 - 1698
  • [26] Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura
    Wendt, Ralph
    Voelker, Linus A.
    Brinkkoetter, Paul T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 382 - 384
  • [27] Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura
    Lorenz, Judith
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2024, 228 (05): : 410 - 411
  • [28] Thrombotic Thrombocytopenic Purpura: Relationship of Infection and ADAMTS13
    Watanaboonyongcharoen, P.
    Brecher, M. E.
    Schultz, E. F.
    Hay, S. N.
    Park, Y. A.
    TRANSFUSION, 2012, 52 : 126A - 127A
  • [29] Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura
    Asmis, Lars M. M.
    Serra, Andreas
    Krafft, Alexander
    Licht, Abraham
    Leisinger, Elke
    Henschkowski-Serra, Jana
    Ganter, Michael T. T.
    Hauptmann, Steffen
    Tinguely, Marianne
    Hovinga, Johanna A. Kremer A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (25): : 2356 - 2361
  • [30] Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura
    Cataland, Spero R.
    Wu, Haifeng M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (04) : 437 - 444